Filgrastim Completed Phase 2 Trials for Plasma Cell Neoplasms / Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00028600Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma